600833 第一医药
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)1.9865.02815.2609.14216.668
总资产报酬率 ROA (%)1.1602.8868.4864.5768.511
投入资产回报率 ROIC (%)1.5403.75011.1356.09811.614

边际利润分析
销售毛利率 (%)14.69316.03116.63019.10120.525
营业利润率 (%)6.4573.50910.8645.4387.178
息税前利润/营业总收入 (%)5.9283.22710.5616.1537.199
净利润/营业总收入 (%)4.8832.7488.5434.9075.405

收益指标分析
经营活动净收益/利润总额(%)0.1162.7493.03823.417118.757
价值变动净收益/利润总额(%)2.52214.5476.14320.3082.313
营业外收支净额/利润总额(%)-1.0711.7143.79115.791-0.059

偿债能力分析
流动比率 (X)1.6931.5861.7391.6511.508
速动比率 (X)1.0981.0531.2201.1601.147
资产负债率 (%)40.15142.07542.20445.87452.985
带息债务/全部投入资本 (%)7.96212.53714.19314.96428.255
股东权益/带息债务 (%)1,000.102602.232518.897482.544218.547
股东权益/负债合计 (%)147.812136.547135.894117.16788.083
利息保障倍数 (X)-12.867-9.424-14.425-20.157277.658

营运能力分析
应收账款周转天数 (天)36.13131.93740.54447.48525.182
存货周转天数 (天)78.49969.56175.37081.56346.838